CBT
TTPH

Central Bank & Trust’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Central Bank & Trust’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25
Closed -$4K – 400
2015
Q3 		$4K Buy
+25
New +$18.3K ﹤0.01% 352

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Central Bank & Trust's TTPH Position: Q4 2015 in Review

Central Bank & Trust sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2015, closing a stake of 25 shares — an estimated $4K sold.

Central Bank & Trust first reported a position in TTPH in Q3 2015 and held it in 1 quarter. The position peaked at $4K in Q3 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

  • Central Bank & Trust reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Central Bank & Trust sold 25 Tetraphase Pharmaceuticals, Inc. shares in Q4 2015, an estimated $4K.
  • Central Bank & Trust first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Central Bank & Trust's Tetraphase Pharmaceuticals, Inc. position peaked at $4K in Q3 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Central Bank & Trust's 13F filing for Q4 2015, filed 12 Jan 2016.